<html>
<head>
   <title>Dietary Approaches to Lowering Cholesterol</title>
   <meta name="GENERATOR" content="Mozilla/2.0GoldB1 (Win32)">
   <meta name="Author" content="Alex Sevanian and Michael Bolger">
</head>
<body text="#000000" bgcolor="#C0C0C0" link="#0000EE" vlink="#551A8B" alink="#FF0000" background="Temple.jpg">

<div align=center><h1><font COLOR="#400040">Dietary Approaches to Lowering
Cholesterol</font> </h1></div>

<div align=center><p><font SIZE=+1><a HREF="mailto:asevan@hsc.usc.edu">Alex
Sevanian</a> and <a HREF="mailto:bolger@zygote.hsc.usc.edu">Michael B.
Bolger</a></font>
<br></p></div>

Number of visitors since 3/4/96:<img src="http://www.usc.edu/cgi-bin/counter?bolger:/hsc/pharmacy/ced/dietchol/DietChl2.htm&width=6">
<h2>Objectives:</h2>

<p>At the end of the next X hr of continuing education, the pharmacist
should be able to:</p>

<ol>
<li>Describe the latest evidence for the multifactorial nature of atherosclerosis,
and the impact of dietary fats and fat soluble antioxidant vitamins. </li>

<li>Review the mechanism of oxyradical formation, the impact on lipoprotein
and cell oxidation, and how antioxidants inhibit these oxidative processes.</li>

<li>Understand the evidence for the presence of oxidized lipoproteins in
humans and their relationship to disease progression. </li>

<li>Identify the latest antioxidant administration levels and how they
impact on other lipid lowering therapies for the treatment of atherogenesis.
</li>
</ol>

<p>
<hr></p>

<h2>Outline: </h2>

<ol>
<li><a HREF="impact.htm">Impact of dietary fats on plasma cholesterol and
atherosclerosis risk.</a> </li>

<ol>
<li>Effect of dietary cholesterol content on plasma cholesterol levels
</li>

<li>The influence of polyunsaturated vs saturated fats on plasma cholesterol
</li>

<li>Cardiovascular disease-related deaths and fat intake </li>

<li>Intake of foods and/or supplements with antioxidant vitamins and its
impact on CHD </li>

<li>The fat soluble vitamins - the special relationship to fat intake </li>
</ol>

<li><a HREF="evidence.htm">Evidence for oxidized lipoproteins in humans
and animal models of atherosclerosis</a> </li>

<ol>
<li>Modified lipoproteins in the vessel wall </li>

<li>Modified lipoproteins in the plasma </li>

<li>Relationships between the levels of modified lipoproteins and disease
progression </li>

<li>Relationships between the levels of antioxidant vitamins and disease
progression </li>
</ol>

<li><a HREF="effects.htm">Effects of oxidized lipids and oxidized low density
lipoproteins on vascular cells (The Modified Lipoprotein Hypothesis)</a>
</li>

<ol>
<li>Cell injury and death </li>

<li>Induction of inflammatory factors and cytokines </li>

<li>Mechanisms for stimulated cell division </li>
</ol>

<li><a HREF="action.htm">The action of antioxidants and antioxidant vitamins</a>
</li>

<ol>
<li>Reaction of antioxidant compounds with oxyradical species </li>

<li>Inhibition of lipid peroxidation by specific antioxidants: <b>the special
role of vitamin E and selenium</b> </li>

<li>How antioxidants inhibit low density lipoprotein oxidation </li>

<li>Examples of inhibition of oxidant-induced responses by antioxidants
</li>
</ol>

<li><a HREF="exam.htm">Examination Form for Continuing Education Credit</a></li>
</ol>

<p>
<hr          width="100%"></p>

</body>
</html>
